International Journal of Hematology

, Volume 78, Issue 4, pp 312–320 | Cite as

Leukemogenesis of Adult T-Cell Leukemia

Progress in hematology

Abstract

Adult T-cell leukemia (ATL) is one of the most aggressive hematologic malignancies and is caused by human T-cell leukemia virus type I (HTLV-I). Tax, encoded by the HTLV-I pX region, has been recognized by its pleiotropic actions as a critical accessory protein playing a central role in leukemogenesis. However, fresh ATL cells frequently lose Tax protein expression via several mechanisms, such as genetic and epigenetic changes in the provirus. Furthermore, there is a long latency period before the onset of ATL, indicating the multistep mechanisms of leukemogenesis.Therefore, additional factors, including other viral proteins, genetic and epigenetic changes of the host genome, and alterations in the gene expression and immune systems of the host cells, may be implicated in ATL leukemogenesis. This review summarizes recent advances in the understanding of ATL leukemogenesis.

Key words

Adult T-cell leukemia Human T-cell leukemia virus type I Multistep leukemogenesis Provirus Clonal expansion 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T-cell leukemia in Japan. In: Seno S, Takaku F, Irino S, eds.Topics in Hematology, the 16th International Congress of Hematology, 1976, Kyoto, Japan. Amsterdam, the Netherlands: Excerpta Medica; 1977:73–77.Google Scholar
  2. 2.
    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases.Blood. 1977;50:481–492.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.Proc Natl Acad Sci U S A. 1980;77:7415–7419.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.Proc Natl Acad Sci U S A. 1981;78:6476–6480.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia.Oncogene. 2003;22:5131–5140.CrossRefPubMedGoogle Scholar
  6. 6.
    Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.Proc Natl Acad Sci U SA. 1983;80:3618–3622.CrossRefGoogle Scholar
  7. 7.
    Aldovini A, De Rossi A, Feinberg MB, Wong-Staal F, Franchini G. Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA.Proc Natl Acad Sci U S A. 1986;83:38–42.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Albrecht B, Lairmore MD. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.Microbiol Mol Biol Rev. 2002;66:396–406.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.Annu Rev Immunol. 2001;19:475–496.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Fujii M, Iwai K, Oie M, et al. Activation of oncogenic transcription factor AP-1 in T-cells infected with human T-cell leukemia virus type 1.AIDS Res Hum Retroviruses. 2000;16:1603–1606.CrossRefPubMedGoogle Scholar
  11. 11.
    Mori N, Morishita M, Tsukazaki T, et al. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREBbinding protein/p300.Blood. 2001;97:2137–2144.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ. Human T-cell lymphotropic virus type 1 Tax inhibits transforming growth factor-β signaling by blocking the association of Smad proteins with Smadbinding element.J Biol Chem. 2002;277:33766–33775.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ding W, Albrecht B, Luo R, et al. Endoplasmic reticulum andcis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.J Virol. 2001;75:7672–7682.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.Blood. 1998;91:4701–4707.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Albrecht B, Collins ND, Burniston MT, et al. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.J Virol. 2000;74:9828–9835.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ding W, Albrecht B, Kelley RE, et al. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T-cells.J Virol. 2002;76:10374–10382.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Bartoe JT, Albrecht B, Collins ND, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.J Virol. 2000;74:1094–1100.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).J Emerg Med. 2000;18:109–119.CrossRefPubMedGoogle Scholar
  19. 19.
    Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan.Int J Cancer. 2000;85:319–324.CrossRefPubMedGoogle Scholar
  20. 20.
    Takatsuki K, Yamaguchi K, Matsuoka M. ATL and HTLV-I-related diseases. In: Takatsuki K, ed.Adult T-Cell Leukemia. New York, NY: Oxford University Press; 1994:1–27.Google Scholar
  21. 21.
    Hanchard B. Adult T-cell leukemia/lymphoma in Jamaica: 1986–1995.J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S20-S25.CrossRefPubMedGoogle Scholar
  22. 22.
    Okamoto T, Ohno Y, Tsugane S, et al. Multi-step carcinogenesis model for adult T-cell leukemia.Jpn J Cancer Res. 1989;80:191–195.CrossRefPubMedGoogle Scholar
  23. 23.
    Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.Nature. 1984;309:640–642.CrossRefPubMedGoogle Scholar
  24. 24.
    Etoh K, Yamaguchi K, Tokudome S, et al. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors.Int J Cancer. 1999;81:859–864.CrossRefPubMedGoogle Scholar
  25. 25.
    Iga M, Okayama A, Stuver S, et al. Genetic evidence of transmission of human T-cell lymphotropic virus type 1 between spouses.J Infect Dis. 2002;185:691–695.CrossRefPubMedGoogle Scholar
  26. 26.
    Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.Cancer Res. 1997;57:4862–4867.PubMedGoogle Scholar
  27. 27.
    Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy.Oncogene. 1998;17:77–82.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia.Blood. 1992;79:477–480.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.Blood. 1992;80:3205–3216.PubMedGoogle Scholar
  30. 30.
    Nishimura S, Asou N, Suzushima H, et al. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T-cell leukemia.Leukemia. 1995;9:598–604.PubMedGoogle Scholar
  31. 31.
    Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia.Blood. 1995;85:2699–2704.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Uchida T, Kinoshita T, Watanabe T, et al. The CDKN2 gene alterations in various types of adult T-cell leukaemia.Br J Haematol. 1996;94:665–670.CrossRefPubMedGoogle Scholar
  33. 33.
    Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia.Cancer Res. 2000;60:1043–1048.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Morosetti R, Kawamata N, Gombart AF, et al. Alterations of the p27KIP1 gene in non-Hodgkin’s lymphomas and adult T-cell leukemia/lymphoma.Blood. 1995;86:1924–1930.PubMedGoogle Scholar
  35. 35.
    Hatta Y, Yamada Y, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T-cell leukemia/lymphoma (ATL).Leukemia. 1997;11:984–989.CrossRefGoogle Scholar
  36. 36.
    Takeuchi S, Takeuchi N, Tsukasaki K, et al. Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma.Leuk Lymphoma. 2003;44:699–701.CrossRefGoogle Scholar
  37. 37.
    Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.Blood. 1998;91:3935–3942.Google Scholar
  38. 38.
    Maeda T, Yamada Y, Moriuchi R, et al. Fas gene mutation in the progression of adult T-cell leukemia.J Exp Med. 1999;189:1063–1071.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Miyamoto Y, Yamaguchi K, Nishimura H, et al. Familial adult T-cell leukemia.Cancer. 1985;55:181–185.CrossRefGoogle Scholar
  40. 40.
    Tsukasaki K, Miller CW, Kubota T, et al. Tumor necrosis factor β polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.Cancer Res. 2001;61:3770–3774.PubMedGoogle Scholar
  41. 41.
    Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression of the Tax gene of type I human T-cell leukemia virus in human T-cells activates specific cellular genes involved in growth.Proc Natl Acad Sci U S A. 1988;85:9733–9737.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Muraoka O, Kaisho T, Tanabe M, Hirano T. Transcriptional activation of the interleukin-6 gene by HTLV-1 p40tax through an NFkappa B-like binding site.Immunol Lett. 1993;37:159–165.CrossRefPubMedGoogle Scholar
  43. 43.
    Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T-cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site.Proc Natl Acad Sci U S A. 1998;95:2452–2457.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families.Oncogene. 1993;8:3189–3197.PubMedGoogle Scholar
  45. 45.
    Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.Science. 1988;241:1652–1655.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Fujii M, Sassone-Corsi P, Verma IM. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.Proc Natl Acad Sci U S A. 1988;85:8526–8530.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Fujii M, Niki T, Mori T, et al. HTLV-1 Tax induces expression of various immediate early serum responsive genes.Oncogene. 1991;6:1023–1029.PubMedGoogle Scholar
  48. 48.
    Cereseto A, Diella F, Mulloy JC, et al. p53 functional impairment and high p21waf1/cip1 expression in human T- cell lymphotropic/ leukemia virus type I-transformed T-cells.Blood. 1996;88:1551–1560.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement ofLeukemogenesis of ATL 319 Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/ Cip1/Sdi1.Oncogene. 1996;12:1645–1652.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Iwanaga R, Ohtani K, Hayashi T, Nakamura M. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.Oncogene. 2001;20:2055–2067.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Tsukahara T, Kannagi M, Ohashi T, et al. Induction of Bcl-xL expression by human T-cell leukemia virus type 1 Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax.J Virol. 1999;73:7981–7987.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Mamane Y, Sharma S, Grandvaux N, Hernandez E, Hiscott J. IRF-4 activities in HTLV-I-induced T-cell leukemogenesis.J Interferon Cytokine Res. 2002;22:135–143.CrossRefPubMedGoogle Scholar
  53. 53.
    Hayashibara T, Yamada Y, Mori N, et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL.Biochem Biophys Res Commun. 2003;300:128–134.CrossRefPubMedGoogle Scholar
  54. 54.
    Jeang KT, Widen SG, Semmes OJ. 4th,Wilson SH. HTLV-I transactivator protein,Tax, is a trans-repressor of the human beta-polymerase gene.Science. 1990;247:1082–1084.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Lemasson I, Robert-Hebmann V, Hamaia S, Duc Dodon M, Gazzolo L, Devaux C. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.J Virol. 1997;71:1975–1983.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Suzuki T, Uchida-Toita M, Yoshida M. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.Oncogene. 1999;18:4137–4143.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Ruckes T, Saul D, Van Snick J, Hermine O, Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309.Blood. 2001;98:1150–1159.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Fujii K, Ishimaru F, Nakase K, et al. Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma.BrJ Haematol. 2003;120:986–989.CrossRefGoogle Scholar
  59. 59.
    Kiyokawa T, Yamaguchi K, Takeya M, et al. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia.Cancer. 1987;59:1187–1191.CrossRefPubMedGoogle Scholar
  60. 60.
    Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.J Exp Med. 1999;190:1741–1754.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cells.Blood. 2002;99:634–640.CrossRefPubMedGoogle Scholar
  62. 62.
    Wano Y, Hattori T, Matsuoka M, et al. Interleukin 1 gene expression in adult T-cell leukemia.J Clin Invest. 1987;80:911–916.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Niitsu Y, Urushizaki Y, Koshida Y, et al. Expression of TGF-βgene in adult T-cell leukemia.Blood. 1988;71:263–266.PubMedGoogle Scholar
  64. 64.
    Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T-cell leukemia virus type 1 (HTLV-1) carriers and adult T-cell leukemia patients that can be trans-activated by HTLV-1 tax gene.J Exp Med. 1990;172:759–765.CrossRefPubMedGoogle Scholar
  65. 65.
    Harhaj EW, Good L, Xiao G, Sun SC. Gene expression profiles in HTLV-I-immortalized T-cells: deregulated expression of genes involved in apoptosis regulation.Oncogene. 1999;18:1341–1349.CrossRefPubMedGoogle Scholar
  66. 66.
    de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F. Gene expression array of HTLV type 1-infected T-cells: up-regulation of transcription factors and cell cycle genes.AIDS Res Hum Retroviruses. 2000;16:1695–1700.CrossRefGoogle Scholar
  67. 67.
    Ng PW, Iha H, Iwanaga Y, et al. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation.Oncogene. 2001;20:4484–4496.CrossRefPubMedGoogle Scholar
  68. 68.
    Pise-Masison CA, Radonovich M, Mahieux R, et al. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes.Cancer Res. 2002;62:3562–3571.PubMedGoogle Scholar
  69. 69.
    Wodarz D, Hall SE, Usuku K, et al. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.Proc R Soc Lond B Biol Sci. 2001;268:1215–1221.CrossRefGoogle Scholar
  70. 70.
    Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.Br J Haematol. 1996;94:713–715.CrossRefPubMedGoogle Scholar
  71. 71.
    Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T-cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant. 2001;27:15–20.CrossRefPubMedGoogle Scholar
  72. 72.
    Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan.Int J Cancer. 2001;91:869–875.CrossRefPubMedGoogle Scholar
  73. 73.
    Yashiki S, Fujiyoshi T, Arima N, et al. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T-cell leukemia: the limited recognition of HTLV type 1 Tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 Tax CD8+ cytotoxic T lymphocytes.AIDS Res Hum Retroviruses. 2001;17:1047–1061.CrossRefPubMedGoogle Scholar
  74. 74.
    Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.Nature. 1990;348:245–248.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Kannagi M, Harada S, Maruyama I, et al. Predominant recognition of human T-cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T-cells directed against HTLV-I-infected cells.Int Immunol. 1991;3:761–767.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.Blood. 1996;88:3065–3073.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-Itax during the development of adult T-cell leukemia.Blood. 2001;97:987–993.CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Koiwa T, Hamano-Usami A, Ishida T, et al. 5′-long terminal repeatselective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.J Virol. 2002;76:9389–9397.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Kibler KV, Jeang KT. Taxing the cellular capacity for repair: human T-cell leukemia virus type 1, DNA damage, and adult T-cell leukemia.J Natl Cancer Inst. 1999;91:903–904.CrossRefPubMedGoogle Scholar
  80. 80.
    White JD, Zaknoen SL, Kasten-Sportes C, et al. Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma.Cancer. 1995;75:1598–1607.CrossRefPubMedGoogle Scholar
  81. 81.
    Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.Jpn J Cancer Res. 1987;78:639–642.PubMedGoogle Scholar
  82. 82.
    Sadahira Y, Nishihara H, Shimizu M, et al. Epstein-Barr virusassociated Hodgkin’s disease in HTLV-I seropositive patients: a report of two cases.Pathol Int. 1998;48:67–73.CrossRefPubMedGoogle Scholar
  83. 83.
    Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.Int J Cancer. 1994;56:337–340.CrossRefPubMedGoogle Scholar
  84. 84.
    Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.Blood. 2001;97:3177–3183.CrossRefGoogle Scholar
  85. 85.
    Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. CD8+T-cells are an in vivo reservoir for human T-cell lymphotropic virus type I.Blood. 2001;98:1858–1861.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Hanon E, Stinchcombe JC, Saito M, et al. Fratricide among CD8+T lymphocytes naturally infected with human T-cell lymphotropic virus type I.Immunity. 2000;13:657–664.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Kannagi M, Ohashi T, Hanabuchi S, et al. Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease.AIDS Res Hum Retroviruses. 2000;16:1737–1740.CrossRefPubMedGoogle Scholar
  88. 88.
    Ohshima K, Haraoka S, Yoshioka S, et al. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.Cancer Lett. 2000;158:141–150.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Yamada Y, Sugawara K, Hata T, et al. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor α on ATL cells.Blood. 1998;91:4265–4272.PubMedGoogle Scholar
  90. 90.
    Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T-cells.Blood. 2002;99:1505–1511.CrossRefPubMedGoogle Scholar
  91. 91.
    Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.Blood. 2000;95:30–38.Google Scholar
  92. 92.
    Arai M, Ohashi T, Tsukahara T, et al. Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF.Virology. 1998;241:298–303.CrossRefPubMedGoogle Scholar
  93. 93.
    Mori N, Nunokawa Y, Yamada Y, Ikeda S, Tomonaga M, Yamamoto N. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.Blood. 1999;94:2862–2870.PubMedGoogle Scholar
  94. 94.
    Mori N, Sato H, Hayashibara T, et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.Blood. 2002;99:1341–1349.CrossRefPubMedGoogle Scholar
  95. 95.
    Miura S, Ohtani K, Numata N, et al. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.Mol Cell Biol. 1991;11:1313–1325.CrossRefPubMedPubMedCentralGoogle Scholar
  96. 96.
    Imura A, Hori T, Imada K, et al. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration.Blood. 1997;89:2951–2958.PubMedGoogle Scholar
  97. 97.
    Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells.Virology. 1997;231:135–140.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2003

Authors and Affiliations

  1. 1.Institute for Virus ResearchKyoto UniversityKyotoJapan

Personalised recommendations